| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK-106 hydrochloride |
|---|
| Description | GSK-106 is a useful negative control for PAD4 inhibitors (GSK-121 and GSK-484). It does not inhibit PAD4 nor does it prevent the citrullination of PAD4 target proteins or the formation of neutrophil extracellular traps in mouse or human neutrophils (IC50s > 100 μM). MW: 437.97. Purity ≥98% |
|---|
| Size | 500 μg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (3-Aminopiperidin-1-yl)(2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzo[d]imidazol-6-yl)methanone hydrochloride |
|---|
| Gene, Accession, CAS # | CAS: 1652591-82-6 |
|---|
| Catalog # | B1036-500 |
|---|
| Price | |
|---|
| Order / More Info | GSK-106 hydrochloride from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|